Skip to main content
European Commission logo print header

Feasibility of medical technology assessment methodology for industry


Technology developments play an important and increasing role in health care provis Abstract (6) The admittance of these provisions is based on the principle of "Evidence based medi Medical technology has therefore to fulf1ll criteria as appropriateness for medical pur added value in medicine, cost effectivity. Medical Technology products are as yet seldomly e with these criteria in mind; most clinical evaluations respond only to the first criterion. Medical Technology assessment is nowadays an accepted tool in health care to prove cost effe ness and the other criteria. However, to apply MTA methodologies as an instrument for evalui products is relatively new and has to answer a number of conditions before being accepted by and health care authorities. This grant application is focussed on defining some of the necessary conditions before applyir proposal for a cooperative research project. Main questions are: verification of adequacy, appr ness and feasibility of MTA methodology for industry, validation of the MTA methodology f single products instead of the generic technique application, the adequacy of MTA methodolo the criteria /rules for application of MTA. The Exploratory Award phase has as principal objectives: selection of industrial partners (via organization), experimental study cases, definition of worktasks, the preparation of the final v gramme and a feasibility research study on the verification of MTA methodologies, novelty a acceptibility of MTA for industry. Tools used for this phase are literature studies, comparison clinical evaluation methodologies, outcome evaluation of methodologies used and the applica MTA for single products. Results will be used for an enquiry on the neccessity and acceptabil MTA methodologies for industry.


Data not available

Call for proposal

Data not available


Medical Consultancy BV
9712 NZ Groningen

See on map

EU contribution
No data

Participants (2)